retatrutide women results Before & After: What to Expect Week by Week Demand for Unapproved Weight-Loss Drug

Cycling versus continuous use Some researchers discuss cycling retatrutide, using it for a defined period, stopping, and resuming if weight regain occurs

The report also covers current obesity treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the markets underlying potential

10.1038/s41392-024-01757-9 32 GuoS.ZhangQ.GuoY.YinX.ZhangP.MaoT.et al (2025)

Adherence to GLP-1s better than earlier reported Source: Marshall, LZ et al Trends in 1-year persistence and adherence among initiators of high-potency, weight lossindicated glucagon-like peptide 1 receptor agonists, J Man Care Pharm February 27, 2026 Multiple studies have reported low adherence to GLP-1 medications to treat obesity, and some have cited this as a reason why employers should not cover these medications

Safety Takeaway Cagrilintide appears to be safe and effective under medical supervision, but like other appetite-regulating peptides, it requires careful dosing and monitoring especially when stacked with GLP-1 agonists or used in people with diabetes